Home

Jason Campagna

CIK 1793338 · Chief Medical Officer · last filed 2025-02-26

Jason Campagna is a Chief Medical Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for QTTB, was dated Feb 26, 2025. Across all open-market trades the lifetime net is −$157.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $598.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$598.1K

Companies

2

Total Filings

17

Lifetime Open-Market Net

-$157.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QTTB Chief Medical Officer 37,500 $15.95 $598.1K $0 2 2025-02-26
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Chief Medical Officer 20,531 $19.00 $390.1K -$157.7K 15 2021-01-26

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-02-26 QTTB Mixed +37,500 $0 EDGAR
2024-03-27 QTTB Grant (A) — $0 EDGAR
2021-01-26 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +12,600 $0 EDGAR
2021-01-05 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −666 -$16.5K EDGAR
2020-10-05 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −112 -$4.7K EDGAR
2020-09-17 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −69 -$3.0K EDGAR
2020-08-20 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Sell (S) −1,192 -$56.5K EDGAR
2020-07-06 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −112 -$5.2K EDGAR
2020-06-17 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −70 -$5.4K EDGAR
2020-04-03 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −112 -$6.5K EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.